Kevin N. Heller - 21 Mar 2022 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Reporting relationship: Executive Vice President, Research and Development
Issuer ticker: JSPR
Reported as of: 21 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Mar 2022, 18:04:14 UTC
Prior SEC filing: 01 Oct 2021
Source filing: View source filing
Reporting owner signature: /s/ Jeet Mahal, as Attorney-in-Fact

Key filing fact

Kevin N. Heller filed Form 4 for Jasper Therapeutics, Inc. (JSPR) on 23 Mar 2022.

Key facts

This page summarizes Kevin N. Heller's Form 4 filing for Jasper Therapeutics, Inc. (JSPR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 Mar 2022, 18:04.

Change

Previous filing in this sequence was filed on 01 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JSPR transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +7,500
Change %
Price: $0.000000
Shares after: 7,500
Date: 21 Mar 2022
Ownership: Direct
Underlying class: Voting Common Stock
Underlying amount: 7,500
Exercise price: $3.54
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/4th of the shares subject to the option shall vest on December 7, 2022, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

SEC remarks

Executive Vice President, Research and Development